"Only 500 doses of annual sales are required to breakeven", according to MacDonald..
- Forums
- ASX - By Stock
- OSL
- Ann: G-BA Approval received for OncoSil Device
OSL
oncosil medical ltd
Add to My Watchlist
0.00%
!
95.0¢

Ann: G-BA Approval received for OncoSil Device, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
95.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.51M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 123 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 46 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 123 | 1.000 |
1 | 5 | 0.960 |
2 | 16677 | 0.950 |
1 | 819 | 0.940 |
2 | 1142 | 0.910 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 46 | 2 |
1.090 | 375 | 1 |
1.150 | 2548 | 2 |
1.190 | 9813 | 2 |
1.200 | 65603 | 3 |
Last trade - 09.05am 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
Day chart unavailable
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online